{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:52:59Z","timestamp":1792590779632,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/gt.2012.56","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T06:26:29Z","timestamp":1342679189000},"page":"467-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model"],"prefix":"10.1038","volume":"20","author":[{"given":"L","family":"Contreras-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G K","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hileeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"L\u00f3pez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Calonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Seijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"BFgt201256_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","volume":"2","author":"ME Stern","year":"2004","unstructured":"Stern ME, Pflugfelder SC . Inflammation in dry eye. Ocul Surf 2004; 2: 124\u2013130.","journal-title":"Ocul Surf"},{"key":"BFgt201256_CR2","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work Shop 2007 Ocul Surf 5: 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"BFgt201256_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-4615-5359-5_32","volume":"438","author":"IK Gipson","year":"1998","unstructured":"Gipson IK, Inatomi T . Cellular origin of mucins of the ocular surface tear film. Adv Exp Med Biol 1998; 438: 221\u2013227.","journal-title":"Adv Exp Med Biol"},{"key":"BFgt201256_CR4","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1167\/iovs.11-7655","volume":"52","author":"RM Corrales","year":"2011","unstructured":"Corrales RM, Narayanan S, Fern\u00e1ndez I, Mayo A, Galarreta DJ, Fuentes-P\u00e1ez G et al. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci 2011; 52: 8363\u20138369.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt201256_CR5","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1167\/iovs.07-0770","volume":"48","author":"IK Gipson","year":"2007","unstructured":"Gipson IK . The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci 2007; 48: 4390\u20134398.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt201256_CR6","first-page":"1004","volume":"43","author":"P Argueso","year":"2002","unstructured":"Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK . Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 2002; 43: 1004\u20131011.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt201256_CR7","first-page":"2483","volume":"42","author":"KS Kunert","year":"2001","unstructured":"Kunert KS, Keane-Myers AM, Spurr-Michaud S, Tisdale AS, Gipson IK . Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2001; 42: 2483\u20132489.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt201256_CR8","first-page":"2602","volume":"39","author":"Y Danjo","year":"1998","unstructured":"Danjo Y, Watanabe H, Tisdale AS, George M, Tsumura T, Abelson MB et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 1998; 39: 2602\u20132609.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt201256_CR9","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JW Bainbridge","year":"2008","unstructured":"Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008; 358: 2231\u20132239.","journal-title":"N Engl J Med"},{"key":"BFgt201256_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/jgm.586","volume":"6","author":"R Rota","year":"2004","unstructured":"Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A et al. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 2004; 6: 992\u20131002.","journal-title":"J Gene Med"},{"key":"BFgt201256_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","volume":"62","author":"M de la, Fuente","year":"2010","unstructured":"de la, Fuente M, Ravina M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ . Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 2010; 62: 100\u2013117.","journal-title":"Adv Drug Deliv Rev"},{"key":"BFgt201256_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1517\/17425240902762818","volume":"6","author":"P Paolicelli","year":"2009","unstructured":"Paolicelli P, de la, Fuente M, Sanchez A, Seijo B, Alonso MJ . Chitosan nanoparticles for drug delivery to the eye. Expert Opin Drug Deliv 2009; 6: 239\u2013253.","journal-title":"Expert Opin Drug Deliv"},{"key":"BFgt201256_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","volume":"29","author":"Y Diebold","year":"2010","unstructured":"Diebold Y, Calonge M . Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 2010; 29: 596\u2013609.","journal-title":"Prog Retin Eye Res"},{"key":"BFgt201256_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.visres.2007.07.012","volume":"48","author":"X Cai","year":"2008","unstructured":"Cai X, Conley S, Naash M . Nanoparticle applications in ocular gene therapy. Vision Res 2008; 48: 319\u2013324.","journal-title":"Vision Res"},{"key":"BFgt201256_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1021\/mp200155t","volume":"8","author":"G Konat Zorzi","year":"2011","unstructured":"Konat Zorzi G, Contreras-Ruiz L, Parraga JE, Lopez-Garcia A, Romero Bello R, Diebold Y et al. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles. Mol Pharm 2011; 8: 1783\u20131788.","journal-title":"Mol Pharm"},{"key":"BFgt201256_CR16","unstructured":"Sanchez A, Alonso MJ . Nanoparticular carriers for ocualr drug delivery. Torchilin VP (ed). Nanoparticuales as Drug Carriers 2009."},{"key":"BFgt201256_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman J, Oberle V, Zuhorn IS, Hoekstra D . Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004; 377: 159\u2013169.","journal-title":"Biochem J"},{"key":"BFgt201256_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/10611860400015910","volume":"12","author":"L Rabinovich-Guilatt","year":"2004","unstructured":"Rabinovich-Guilatt L, Couvreur P, Lambert G, Dubernet C . Cationic vectors in ocular drug delivery. J Drug Target 2004; 12: 623\u2013633.","journal-title":"J Drug Target"},{"key":"BFgt201256_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/gt.2008.16","volume":"15","author":"M de la, Fuente","year":"2008","unstructured":"de la, Fuente M, Seijo B, Alonso MJ . Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Therapy 2008; 15: 668\u2013676.","journal-title":"Gene Therapy"},{"key":"BFgt201256_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jgm.1011","volume":"9","author":"E Toropainen","year":"2007","unstructured":"Toropainen E, Hornof M, Kaarniranta K, Johansson P, Urtti A . Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops. J Gene Med 2007; 9: 208\u2013216.","journal-title":"J Gene Med"},{"key":"BFgt201256_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mabi.201100005","volume":"11","author":"GK Zorzi","year":"2011","unstructured":"Zorzi GK, Parraga JE, Seijo B, Sanchez A . Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy. Macromol Biosci 2011; 11: 905\u2013913.","journal-title":"Macromol Biosci"},{"key":"BFgt201256_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/ICO.0b013e3181bd9eee","volume":"29","author":"L Contreras-Ruiz","year":"2010","unstructured":"Contreras-Ruiz L, de la Fuente M, Garcia-Vazquez C, Saez V, Seijo B, Alonso MJ et al. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea 2010; 29: 550\u2013558.","journal-title":"Cornea"},{"key":"BFgt201256_CR23","first-page":"632","volume":"43","author":"D Dursun","year":"2002","unstructured":"Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME et al. A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2002; 43: 632\u2013638.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt201256_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.exer.2004.07.002","volume":"79","author":"S Barabino","year":"2004","unstructured":"Barabino S, Chen W, Dana MR . Tear film and ocular surface tests in animal models of dry eye: uses and limitations. Exp Eye Res 2004; 79: 613\u2013621.","journal-title":"Exp Eye Res"},{"key":"BFgt201256_CR25","doi-asserted-by":"crossref","unstructured":"Contreras-Ruiz L, Schulze U, Garc\u00eda-Posadas L, Arranz-Valsero I, L\u00f3pez-Garc\u00eda A, Paulsen F et al. Structural and functional alteration of corneal epithelial barrier under inflammatory conditions. Curr Eye Res 2012, e-pub ahead of print 27 June 2012 doi:10.3109\/02713683.2012.700756.","DOI":"10.3109\/02713683.2012.700756"},{"key":"BFgt201256_CR26","first-page":"S88","volume":"14","author":"MA Lemp","year":"2008","unstructured":"Lemp MA . Management of dry eye disease. Am J Manag Care 2008; 14: S88\u2013101.","journal-title":"Am J Manag Care"},{"key":"BFgt201256_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/archopht.1983.01040020286025","volume":"101","author":"S Kinoshita","year":"1983","unstructured":"Kinoshita S, Kiorpes TC, Friend J, Thoft RA . Goblet cell density in ocular surface disease. A better indicator than tear mucin. Arch Ophthalmol 1983; 101: 1284\u20131287.","journal-title":"Arch Ophthalmol"},{"key":"BFgt201256_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archopht.1984.01040030851031","volume":"102","author":"JD Nelson","year":"1984","unstructured":"Nelson JD, Wright JC . Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984; 102: 1049\u20131051.","journal-title":"Arch Ophthalmol"},{"key":"BFgt201256_CR29","doi-asserted-by":"crossref","unstructured":"Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J et al. Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol 176: 3950\u20133957.","DOI":"10.4049\/jimmunol.176.7.3950"},{"key":"BFgt201256_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ncponc0509","volume":"3","author":"R Nahta","year":"2006","unstructured":"Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ . Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol 2006; 3: 269\u2013280.","journal-title":"Nat Clin Pract Oncol"},{"key":"BFgt201256_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ijc.10410","volume":"99","author":"SA Price-Schiavi","year":"2002","unstructured":"Price-Schiavi SA, Jepson S, Li P, Arango M, Rudland PS, Yee L et al. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance. Int J Cancer 2002; 99: 783\u2013791.","journal-title":"Int J Cancer"},{"key":"BFgt201256_CR32","first-page":"1545","volume":"20","author":"JE Parraga","year":"2009","unstructured":"Parraga JE, Zorzi GK, Seijo B, S\u00e1nchez A . Gelatin nanoparticles for ocular gene delivery. Hum Gene Ther 2009; 20: 1545.","journal-title":"Hum Gene Ther"},{"key":"BFgt201256_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/157340611795564277","volume":"7","author":"R Lopez-Cebral","year":"2011","unstructured":"Lopez-Cebral R, Martin-Pastor M, Parraga JE, Zorzi GK, Seijo B, Sanchez A . Chemically modified gelatin as biomaterial in the design of new nanomedicines. Med Chem 2011; 7: 145\u2013154.","journal-title":"Med Chem"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201256","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:26:11Z","timestamp":1648538771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,19]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFgt201256"],"URL":"https:\/\/doi.org\/10.1038\/gt.2012.56","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717959641.793462979","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,19]]},"assertion":[{"value":"5 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}